Earlier this week, the Sioux Falls Development Foundation made a $3 million investment in SAB Biotherapeutics to bolster the Bio-Tech industry in the area. SAB Biotherapeutics uses genetically engineered cattle to produce human antibodies. CEO and co-founder Dr. Eddie Sullivan discusses his company and the science behind human antibodies.
INNOVATION_SEG_2a.mp3
Second part of Interview
Your browser doesn’t support HTML5 audio